Treatment of Severe Heart Failure by Ultrafiltration
Ultrafiltration for the Chronic Treatment of Severe Congestive Heart Failure
1 other identifier
interventional
60
1 country
1
Brief Summary
Patients with severe congestive heart failure show increased fluid body content which is often resistant to conventional diuretic therapy. Therefore, chronic heart failure patients have frequent access to the emergency room and hospital for hemodynamic instability. Ultrafiltration is a simple renal replacement therapy which reduces fluid overload. The purpose of this study is to determine whether periodic ultrafiltration sessions maintain patients in stable clinical condition and reduce hospitalisations as well as access to emergency heart failure treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Aug 2006
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 3, 2006
CompletedFirst Posted
Study publicly available on registry
August 7, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJanuary 28, 2016
January 1, 2016
6.2 years
August 3, 2006
January 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of hospitalizations for heart failure
End of study
Secondary Outcomes (1)
long term major adverse clinical events including death
End of study
Study Arms (2)
Ultrafiltration
EXPERIMENTALUltrafiltration treatment
Usual treatment
ACTIVE COMPARATORUsual HF treatment
Interventions
Eligibility Criteria
You may qualify if:
- Severe heart failure (NYHA III-IV) with fluid overload
- Ejection fraction \< 40%
- Estimated fluid overload \> 4 kg
You may not qualify if:
- Severe renal insufficiency
- Acute pulmonary edema and/or cardiogenic shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Cardiologico Monzino
Milan, 20138, Italy
Related Publications (1)
Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, Ferramosca E, Borghi C, Santoro A, Agostoni P. Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014 Jan;20(1):9-17. doi: 10.1016/j.cardfail.2013.11.004. Epub 2013 Nov 20.
PMID: 24269855DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Piergiuseppe Agostoni, MD.PhD
Centro Cardiologico Monzino
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
August 3, 2006
First Posted
August 7, 2006
Study Start
August 1, 2006
Primary Completion
October 1, 2012
Study Completion
December 1, 2012
Last Updated
January 28, 2016
Record last verified: 2016-01